Cited by
Cited by
De novo enzyme design using Rosetta3
F Richter, A Leaver-Fay, SD Khare, S Bjelic, D Baker
PloS one 6 (5), e19230, 2011
Molecular dynamics simulations of water and biomolecules with a Monte Carlo constant pressure algorithm
J Åqvist, P Wennerström, M Nervall, S Bjelic, BO Brandsdal
Chemical physics letters 384 (4-6), 288-294, 2004
Enantioselective enzymes by computational design and in silico screening
HJ Wijma, RJ Floor, S Bjelic, SJ Marrink, D Baker, DB Janssen
Angewandte Chemie International Edition 54 (12), 3726-3730, 2015
Potent Inhibitors of the Plasmodium falciparum Enzymes Plasmepsin I and II Devoid of Cathepsin D Inhibitory Activity
K Ersmark, I Feierberg, S Bjelic, E Hamelink, F Hackett, MJ Blackman, ...
Journal of Medicinal Chemistry 47 (1), 110-122, 2004
Cold adaptation of enzyme reaction rates
S Bjelic, BO Brandsdal, J Åqvist
Biochemistry 47 (38), 10049-10057, 2008
Computational design of enone-binding proteins with catalytic activity for the Morita–Baylis–Hillman reaction
S Bjelic, LG Nivón, N Çelebi-Ölçüm, G Kiss, CF Rosewall, ...
ACS chemical biology 8 (4), 749-757, 2013
Computational prediction of structure, substrate binding mode, mechanism, and rate for a malaria protease with a novel type of active site
S Bjelic, J Åqvist
Biochemistry 43 (46), 14521-14528, 2004
Catalysis and linear free energy relationships in aspartic proteases
S Bjelic, J Åqvist
Biochemistry 45 (25), 7709-7723, 2006
Computational inhibitor design against malaria plasmepsins
S Bjelic, M Nervall, H Gutiérrez-de-Terán, K Ersmark, A Hallberg, J Åqvist
Cellular and Molecular Life Sciences 64, 2285-2305, 2007
C2-symmetric inhibitors of Plasmodium falciparum plasmepsin II: synthesis and theoretical predictions
K Ersmark, I Feierberg, S Bjelic, J Hultén, B Samuelsson, J Åqvist, ...
Bioorganic & medicinal chemistry 11 (17), 3723-3733, 2003
Exploration of alternate catalytic mechanisms and optimization strategies for retroaldolase design
S Bjelic, Y Kipnis, L Wang, Z Pianowski, S Vorobiev, M Su, ...
Journal of molecular biology 426 (1), 256-271, 2014
Automating human intuition for protein design
LG Nivón, S Bjelic, C King, D Baker
Proteins: Structure, Function, and Bioinformatics 82 (5), 858-866, 2014
Better together: Elements of successful scientific software development in a distributed collaborative community
J Koehler Leman, BD Weitzner, PD Renfrew, SM Lewis, R Moretti, ...
PLoS Computational Biology 16 (5), e1007507, 2020
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
Y Liu, YL Tan, X Zhang, G Bhabha, DC Ekiert, JC Genereux, Y Cho, ...
Proceedings of the National Academy of Sciences 111 (12), 4449-4454, 2014
The catalytic activity of Abl1 single and compound mutations: Implications for the mechanism of drug resistance mutations in chronic myeloid leukaemia
PS Georgoulia, G Todde, S Bjelic, R Friedman
Biochimica et Biophysica Acta (BBA)-General Subjects 1863 (4), 732-741, 2019
Deciphering the molecular mechanism of FLT3 resistance mutations
PS Georgoulia, S Bjelic, R Friedman
The FEBS Journal, 2020
De Novo-Designed Enzymes as Small-Molecule-Regulated Fluorescence Imaging Tags and Fluorescent Reporters
Y Liu, X Zhang, YL Tan, G Bhabha, DC Ekiert, Y Kipnis, S Bjelic, D Baker, ...
Journal of the American Chemical Society 136 (38), 13102-13105, 2014
Simulations studies of protein kinases that are molecular targets in cancer
R Friedman, S Bjelic
Israel Journal of Chemistry 60 (7), 667-680, 2020
Computational backbone design enables soluble engineering of transferrin receptor apical domain
DJ Sjöström, SA Berger, G Oberdorfer, S Bjelic
Proteins: Structure, Function, and Bioinformatics 88 (12), 1569-1577, 2020
Tuning the binding interface between Machupo virus glycoprotein and human transferrin receptor
DJ Sjöström, A Lundgren, SJ Garforth, S Bjelic
Proteins: Structure, Function, and Bioinformatics 89 (3), 311-321, 2021
The system can't perform the operation now. Try again later.
Articles 1–20